Aldeyra Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Aldeyra Therapeutics stock have an average target of 10, which predicts an increase of 49.93% from the current stock price of 6.67.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$10	$10	$10	$10
Change	+49.93%	+49.93%	+49.93%	+49.93%

Analyst Ratings

The average analyst rating for Aldeyra Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	2	2	2	2	1
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+49.93%	Mar 3, 2025
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+49.93%	Aug 9, 2024
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+49.93%	Aug 2, 2024
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+49.93%	May 6, 2024
Francois Brisebois Oppenheimer	Oppenheimer	Buy Reiterates $10	Buy	Reiterates	$10	+49.93%	May 6, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 211.41M

Revenue Next Year

n/a

EPS This Year

-0.47

from -0.94

EPS Next Year

-0.21

from -0.47

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	85.44M	51.18M	161.95M	211.41M
Revenue Growth	-	-	-40.09%	216.42%	30.54%	-	-	-
EPS	-1.11	-1.07	-1.06	-0.64	-0.94	-0.47	-0.21	0.77
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	8.66
No. Analysts	-	-	-	-	-	10	7	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	209.1M	69.4M
Avg	n/a	85.4M	51.2M
Low	n/a	6.9M	37.8M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-18.8%
Avg	-	-	-40.1%
Low	-	-	-55.8%

EPS Forecast

EPS	2025	2026	2027
High	1.71	0.20	1.41
Avg	-0.47	-0.21	0.77
Low	-1.01	-0.59	0.17

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.